1. bookVolume 28 (2020): Issue 2 (April 2020)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Genetic variability of ANG2-35G>C gene as a predictor factor in sepsis

Published Online: 04 May 2020
Page range: 175 - 184
Received: 21 Jan 2020
Accepted: 02 Mar 2020
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

To date it is unknown if there is a predisposition to sepsis. In this respect, genetic studies have been conducted with the aim to find gene variants which can point out a higher predisposition to developing sepsis. The primary objective of this study is to highlight whether the genetic polymorphism of Angiopoietin-2 gene (ANG2-35G>C) is present mainly in septic patients. As secondary objectives we aimed to evaluate if there are any associations between ANG2-35G>C polymorphism and the severity scores Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score (SAPS) as well as routine tests in septic patients such as C reactive protein (CRP), procalcitonin (PCT). We enrolled adult patients admitted to the Intensive Care Unit (ICU). After admission to the ICU and the diagnosis of sepsis, blood samples were collected and the severity scores: APACHE II, SAPS were calculated on the first day of ICU admission. We recorded the following from the blood samples: CRP, PCT, angiopoietine2 (Ang-2). We performed several one-way ANOVA tests to determine any significant mean difference of the analyzed variables. We observed that variant genotypes of ANG2-35G>C gene polymorphism are significantly related to CRP, aspect which increases this biomarker credibility compared with others (i.e., PCT), in septic patients. ANG2-35G>C gene polymorphism is associated with severity scores, APACHE II, and SAPS in sepsis.

Keywords

1. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations, International Forum of Acute Care Trialists. Am J Respir Crit Care Med. 2016; 193(3):259-72. DOI: 10.1164/rccm.201504-0781OC10.1164/rccm.201504-0781OCSearch in Google Scholar

2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8): 801-10. DOI: 10.1001/jama.2016.028710.1001/jama.2016.0287Search in Google Scholar

3. James D. Faix. Biomarkers of sepsis Crit Rev Clin Lab Sci, 2013; 50(1): 23-36. DOI: 10.3109/10408363.2013.76449010.3109/10408363.2013.764490Search in Google Scholar

4. Christaki E, Anyfanti P, Opal SM. Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther 2011; 9:1013-33. DOI: 10.1586/eri.11.12210.1586/eri.11.122Search in Google Scholar

5. László I, Trásy D, Molnár Z. Sepsis: From Pathophysiology to Individualized Patient Care, J Immunol Res. 2015; 2015: 510436. DOI: 10.1155/2015/51043610.1155/2015/510436Search in Google Scholar

6. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-32. DOI: 10.1056/NEJM19880324318120210.1056/NEJM198803243181202Search in Google Scholar

7. Matthew J, Delano, Peter A. The Immune System’s Role in Sepsis Progression, Resolution and Long-Term Outcome. Immunol Rev. 2016; 274(1): 330-53. DOI: 10.1111/imr.1249910.1111/imr.12499Search in Google Scholar

8. Fiedler U, Augustin HG: Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol 2006; 27:552-58. DOI: 10.1016/j.it.2006.10.00410.1016/j.it.2006.10.004Search in Google Scholar

9. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angio-genesis. Science 1997; 277:55-60. DOI: 10.1126/science.277.5322.5510.1126/science.277.5322.55Search in Google Scholar

10. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angio-genesis. Cell 1996; 87:1171-80. DOI: 10.1016/S0092-8674(00)81813-910.1016/S0092-8674(00)81813-9Search in Google Scholar

11. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111: 97-105. DOI: 10.1161/01.CIR.0000151287.08202.8E10.1161/01.CIR.0000151287.08202.8ESearch in Google Scholar

12. Parikh SM, Mammoto T, Schultz A, Yuan HT, Chris-tiani D, Karumanchi SA et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:356-70. DOI: 10.1371/journal.pmed.003004610.1371/journal.pmed.0030046Search in Google Scholar

13. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res. 2001 Feb 16; 49(3):659-70. DOI: 10.1016/S0008-6363(00)00231-510.1016/S0008-6363(00)00231-5Search in Google Scholar

14. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J et al. Angiopoietin-2 functions as an auto-crine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A. 2006 Oct 17; 103(42):15491-6. DOI: 10.1073/pnas.060753810310.1073/pnas.0607538103159253417030814Search in Google Scholar

15. MarikP.E, Taeb A.M. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017; 9(4): 943-45. DOI: 10.21037/jtd.2017.03.12510.21037/jtd.2017.03.125541829828523143Search in Google Scholar

16. Szederjesi J, Georgescu AM, Santini A, Almasy E, Lazar A, Hutanu A, et al. L. Ang-2, Tie-2 si Ang-2/Tie-2 ratio serum levels as diagnostic and prognostic bio-markers of sepsis in critically ill patients. Rev Romana Med Lab, 2016; 24:187-99. DOI: 10.1515/rrlm-2016-000710.1515/rrlm-2016-0007Search in Google Scholar

17. Bányász I, Bokodi G, Vannay A, Szebeni B, Treszl A, Vásárhelyi B, et al. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res. 2006; 31(7-8):685-90. DOI: 10.1080/0271368060080112310.1080/0271368060080112316877277Search in Google Scholar

18. Parikh SM. Dysregulation of the angiopoietin-Tie2 axis in sepsis and ARDS. Virulence. 2013; 4:517-24. DOI: 10.4161/viru.2490610.4161/viru.24906535973723652985Search in Google Scholar

19. Georgescu AM, Bănescu C, Badea I, Moldovan V, Huțanu A, Voidăzan S et al. IL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective study. Rev Romana Med Lab, 2017; 25:75-89. DOI: 10.1515/rrlm-2016-004410.1515/rrlm-2016-0044Search in Google Scholar

20. Tomescu DR, Dima OS, Ungureanu D, Popescu M, Tulbure D, Popescu I. First report of cytokine removal using CytoSorb® in severe noninfectious inflammatory syndrome after liver transplantation. Int J Artif Organs 2016; 16; 39(3):136-40. DOI: 10.5301/ijao.500048910.5301/ijao.500048927079418Search in Google Scholar

21. Bataille A, Galichon P, Ziliotis M, Iman S, Hertig A. Epigenetic changes during sepsis: on your marks! Crit Care. 2015; 19: 358. DOI: 10.1186/s13054-015-1068-510.1186/s13054-015-1068-5460649526467433Search in Google Scholar

22. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. The Journal of Critical Care Medicine 2015; 1(1):18-23. DOI: 10.1515/jccm-2015-000410.1515/jccm-2015-0004595328029967811Search in Google Scholar

23. Georgescu AM, Szederjesi J, Dobreanu M, Copotoiu SM, Voidăzan S, Huțanu A, et al. Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis. Rev Romana Med Lab, 2015; 23(1):59-73. DOI: 10.1515/rrlm-2015-000210.1515/rrlm-2015-0002Search in Google Scholar

24. Corrêa TD, Sanches PR, de Morais LC, Scarin FC, Silva E, Barbas CS et al. Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study. BMC Pulm Med. 2015; 15:144. DOI: 10.1186/s12890-015-0139-310.1186/s12890-015-0139-3464276626559350Search in Google Scholar

25. Vincent JL, Opal SM, Marshall JC. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med. 2010; 38:283-7. DOI: 10.1097/CCM.0b013e-3181b785a2Search in Google Scholar

26. Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit. Care. 2011; 15:R149. DOI: 10.1186/cc1027410.1186/cc10274321902321682927Search in Google Scholar

27. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononu-clear cells in sepsis. Crit. Care Med. 2009; 37:882-8. DOI: 10.1097/CCM.0b013e31819b52fd10.1097/CCM.0b013e31819b52fd19237892Search in Google Scholar

28. Werner JA, Schierding W, Dixon D, MacMillan S, Oppedal D, Muenzer J, et al. Preliminary evidence for leukocyte transcriptional signatures for pediatric ventilator-associated pneumonia. J. Intensive Care Med. 2012; 27(6):362-9. DOI: 10.1177/088506661140683510.1177/088506661140683521606059Search in Google Scholar

29. Dobreanu M, Oprea OR. Laboratory medicine in the era of precision medicine - dream or reality?. Rev Romana Med Lab. 2019;27(2):115-24. DOI: 10.2478/rrlm-2019-002510.2478/rrlm-2019-0025Search in Google Scholar

30. Lazăr A, Georgescu AM, Vitin A, Azamfirei L. Precision Medicine and its role in the treatment of sepsis: a personalised view. Journal of Critical Care Medicine, 2019; 5:90-6. DOI: 10.2478/jccm-2019-001710.2478/jccm-2019-0017669807431431921Search in Google Scholar

31. Johnson SB, Lissauer M, Bochicchio GV Moore R, Cross AS, Scalea TM.. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann. Surg; 2007; 245:611-21. DOI: 10.1097/01. sla.0000251619.10648.3210.1097/01Search in Google Scholar

32. Reinhart K, Bauer,M, Riedemann N.C, New approaches to sepsis: molecular diagnostics and Biomarkers. Clin Microbiol Rev. 2012; 25(4): 609-34. DOI: 10.1128/CMR.00016-1210.1128/CMR.00016-12348575123034322Search in Google Scholar

33. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med. 1999; 340:448-54. DOI: 10.1056/NEJM19990211340060710.1056/NEJM1999021134006079971870Search in Google Scholar

34. Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012; 102:25-36. DOI: 10.1159/00033662910.1159/00033662922507868Search in Google Scholar

35. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39:206-17. DOI: 10.1086/42199710.1086/42199715307030Search in Google Scholar

36. Szederjesi J, Almasy E, Lazăr A, Huțanu A, Badea I, Georgescu A. C. Biomarkers of Severe Sepsis. J Crit Care Med 2015;1(4): 147-53. DOI: 10.1515/jccm-2015-002210.1515/jccm-2015-0022595329529967823Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo